Omvoh (mirikizumab)

pCPA File Number: 22481

Negotiation Status:

Concluded with an LOI

Indication(s):

Ulcerative Colitis

Sponsor/Manufacturer:

Eli Lilly Canada Inc.

CDA-AMC Project Number:

SR0773-000

pCPA Engagement Letter Issued:

2024-03-15

Negotiation Process Concluded:

2024-08-29